Supplemental Figures from Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination

Abstract

<p>The supplemental figures provide supporting data including controls, synergism studies, dose response curves, validation of knockdown, etc.</p>